Logo

American Heart Association

  8
  0


Final ID: TMP6

Intra-arterial Lidocaine Administration of Lidocaine in Middle Meningeal Artery for Treatment of Subarachnoid Hemorrhage-Related Headaches

Abstract Body: Background and Purpose: We report short- and intermediate-term effects on headaches with intra-arterial injection of lidocaine in the middle meningeal artery in patients with severe headaches associated with subarachnoid hemorrhage.

Methods: We treated 7 patients with intra-arterial lidocaine in doses up to 50 mg in each middle meningeal artery via a microcatheter bilaterally (except in one patient). We recorded the maximum intensity of headache (graded by 11-point numeric rating scale) prior to procedure and every day for the next 10 days or discharge, whichever came first. We identified changes in the middle meningeal artery pre- and post-intra-arterial lidocaine administration and quantified from Grade 0 (no change) to Grade 5 (severe narrowing or near occlusion of anterior and posterior dural branches or proximal middle meningeal artery that precludes adequate imaging of distal branches).

Results: We observed improvement in severity of headaches of headache in all 7 subarachnoid hemorrhage patients. The resolution of headache was immediate and complete in 4 patients, unilateral immediate resolution in one patient, and delayed complete resolution in patient. Only one patient met the definition of severe headache (defined as 2 or more days with maximum pain scores of 8 or greater or need for 3 or more different analgesics for 2 or more days) post treatment on Days 4 and 5. One patient had a relapse in headache with the severity matching pre-treatment severity and required a second treatment. On analysis of angiographic data, there was consistent narrowing of middle meningeal arteries after administration of intra-arterial lidocaine and was graded as 5 in 2 arteries, 4 in 10 arteries, and 3 in 2 arteries.

Conclusions: We found that intra-arterial injection of lidocaine can result in consistent amelioration of headache in patients with subarachnoid hemorrhage. The therapeutic benefit may be related to vasoconstriction (reversal of vasodilation) in the middle meningeal arteries after administration of lidocaine.
  • Qureshi, Adnan  ( University of Missouri , Columbia , Missouri , United States )
  • Bains, Navpreet  ( Arrowhead Neurosurgical Medical Gro , Redlands , California , United States )
  • Bhatti, Ibrahim  ( University of Missouri , Columbia , Missouri , United States )
  • Jani, Vishal  ( Creighton University , Omaha , Nebraska , United States )
  • Suri, Fareed  ( ST CLOUD HOSPITAL , Saint Cloud , Minnesota , United States )
  • Bhogal, Pervinder  ( The Royal London Hospital , London , United Kingdom )
  • Author Disclosures:
    Adnan Qureshi: DO have relevant financial relationships ; Ownership Interest:Qureshi Medical LLC:Active (exists now) ; Ownership Interest:QuReVasc LLC:Active (exists now) ; Ownership Interest:DyQure LLC:Active (exists now) | Navpreet Bains: DO NOT have relevant financial relationships | Ibrahim Bhatti: DO NOT have relevant financial relationships | Vishal Jani: No Answer | Fareed Suri: DO NOT have relevant financial relationships | pervinder bhogal: DO NOT have relevant financial relationships
Meeting Info:
Session Info:
You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)